| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |